The Africa Supraglottic Devices market size is expected to reach US$ 14.4 million by 2033 from US$ 13.3 million in 2025. The market is estimated to record a CAGR of 0.9% from 2026 to 2033.
Demand for supraglottic airway devices in Africa is driven by the need for fast, simple airway management, especially in areas with limited access to highly trained anaesthesiology personnel. These devices are considered a safe and practical solution for use in emergency departments, ambulance services, and small surgical facilities where rapid airway control is essential.
Urban centers in Africa are witnessing slow adoption of supraglottic devices, as hospitals upgrade their infrastructure and align themselves with global clinical standards. Growing awareness of patient safety and procedural efficiency is prompting clinicians to consider alternatives to traditional intubation for certain patients. Rising rates of non-communicable diseases and trauma are also increasing the demand for airway management equipment.
However, the budget limitations in public healthcare systems often restrict procurement of newer devices, leading to continued reliance on reusable or traditional airway methods. Furthermore, uneven healthcare infrastructure across countries creates disparities in adoption, with rural and under-resourced areas lagging. Limited training opportunities and practitioner resistance to change also hinder the adoption of supraglottic devices in routine practice.

Key segments that contributed to the derivation of the Africa Supraglottic Devices market analysis are product type, usage type, application, patient type, and end user.
In Africa, healthcare facilities are increasingly adopting minimally invasive airway management techniques to meet rising service demand amid a shortage of specialists. The use of supraglottic airway devices (SGAs) is growing due to their rapid deployment and lower technical skill requirements compared with endotracheal intubation.
This preference is also shaped by the growing demand for surgical and obstetric care across the region. Facilities handling high numbers of cesarean sections, trauma cases, and outpatient procedures benefit from airway devices that reduce procedure time and simplify workflow. SGAs align well with these needs, enabling clinicians to maintain airway control with fewer complications and less reliance on advanced equipment. As a result, they are increasingly being incorporated into standard practice in both public and private healthcare settings.
Another contributing factor is the push toward cost-effective and scalable healthcare delivery. Minimally invasive devices often require less maintenance and can be used with basic monitoring infrastructure, making them suitable for settings with constrained resources. The adoption of single-use SGAs is also gradually increasing, particularly in urban centers, where infection control protocols are becoming stricter.
With a shortage of specialized anesthesiology professionals, there is a growing emphasis on equipping general practitioners, nurses, and emergency personnel with practical airway management skills. Simulation-based training is emerging as an effective approach, allowing healthcare workers to practice device placement in controlled environments before applying these skills in real-world scenarios.
Workshops and hands-on training programs are becoming more common, often supported by teaching hospitals and regional medical institutions. These initiatives focus on building confidence in using SGAs, particularly in emergency and prehospital care, where rapid decision-making is critical. In regions with high trauma incidence or limited access to advanced airway equipment, simulation training helps standardize procedures and reduce variability in patient outcomes. It also enables providers to become familiar with different device types and their appropriate use cases.
Over time, the integration of simulation into formal medical and nursing education is expected to further accelerate adoption. Training institutions are recognizing the value of structured skill development in improving patient safety and clinical efficiency. Even in areas where access to high-fidelity simulators is limited, low-cost training models and peer-led instruction are helping bridge the gap. This growing culture of continuous learning and practical training is likely to support sustained demand for supraglottic devices, as more healthcare providers become proficient and comfortable with their use.
The Africa Supraglottic Devices market is experiencing steady growth, with market size and share analysis reflecting evolving treatment preferences and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, usage type, application, patient type, and end user, highlighting their respective contributions to overall market performance.
By product type, the laryngeal mask airways subsegment dominated the supraglottic devices market in 2025. The dominance of laryngeal mask airways is driven by their ease of insertion, high success rate in securing the airway, reduced risk of complications compared to traditional intubation, and broad adoption in surgical and emergency settings, making them a key revenue contributor for manufacturers.
Based on usage type, the disposable devices subsegment led the market in 2025. Disposable supraglottic devices are preferred due to their reduced risk of cross-contamination, lower sterilization requirements, and convenience for high-volume clinical environments, which supports their widespread adoption across hospitals and emergency care facilities.
In terms of application, the anesthesia subsegment dominated the market in 2025. This leadership is attributed to the frequent use of supraglottic devices in elective and emergency surgical procedures, the increasing number of surgeries worldwide, and the clinical benefits of providing a safe and effective airway without the need for invasive intubation.
By patient type, the adult subsegment dominated the market in 2025. The preference for adult patients is driven by higher procedural volumes in adult surgeries, the established clinical efficacy of supraglottic devices in adult airway management, and increasing adoption in critical care and emergency settings.
Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals have well-established anesthesia and critical care departments, access to advanced airway management devices, trained staff, and the capability to perform a high volume of surgical and emergency procedures requiring reliable airway management.
| Report Attribute | Details |
|---|---|
| Market size in 2025 | US$ 13.3 Million |
| Market Size by 2033 | US$ 14.4 Million |
| CAGR (2026 - 2033) | 0.9% |
| Historical Data | 2022-2024 |
| Forecast period | 2026-2033 |
| Segments Covered | By Product Type
|
|
Regions and Countries Covered
| |
| Africa | Egypt, South Africa, Nigeria, Algeria |
| Market leaders and key company profiles |
|
The "Africa Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:
The geographical scope of the Africa Supraglottic Devices market report is divided into Nigeria, Egypt, South Africa, and Algeria. South Africa held the largest share in 2025.
South Africa has the most developed supraglottic devices market in Africa, supported by a mature healthcare sector and widespread adoption of advanced medical technologies. The country's healthcare system includes well-equipped private hospitals and increasingly developed public facilities, both of which encourage the use of these devices. In particular, private hospitals have been at the forefront of integrating supraglottic airway devices to improve efficiency and clinical outcomes.
The availability of trained personnel supports the use of supraglottic airway devices across a range of procedures, from elective surgery to trauma care. South Africa also benefits from greater access to imported medical devices compared with other African countries. Its well-developed emergency medical system, which requires rapid airway management, further drives adoption. As a result, supraglottic devices are increasingly used in prehospital settings due to their simplicity and effectiveness. However, challenges remain in public healthcare facilities, where budget constraints and high patient volumes limit widespread use.

The Africa Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Africa Supraglottic Devices market are:
The Africa Supraglottic Devices Market is valued at US$ 13.3 Million in 2025, it is projected to reach US$ 14.4 Million by 2033.
As per our report Africa Supraglottic Devices Market, the market size is valued at US$ 13.3 Million in 2025, projecting it to reach US$ 14.4 Million by 2033. This translates to a CAGR of approximately 0.9% during the forecast period.
The Africa Supraglottic Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Africa Supraglottic Devices Market report:
The Africa Supraglottic Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Africa Supraglottic Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Africa Supraglottic Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)